High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection.

Cynamon, M H; Zhang, Y; Harpster, T; Cheng, S; DeStefano, M S

Cynamon, M H; Zhang, Y; Harpster, T; Cheng, S; DeStefano, M S.

Affiliation

Cynamon MH; Department of Medicine, Veterans Affairs Medical Center, and SUNY Health Science Center, Syracuse, New York 13210, USA. Cynamon.Michael@Sycrause.VA.GOV

Antimicrob Agents Chemother ; 43(12): 2922-4, 1999 Dec.

Article in En | MEDLINE | ID: mdl-10582883

Subject(s)

Antitubercular Agents/therapeutic use; Isoniazid/therapeutic use; Mycobacterium tuberculosis/drug effects; Mycobacterium tuberculosis/genetics; Tuberculosis/drug therapy; Animals; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Genes, Bacterial/genetics; Isoniazid/pharmacology; Lung/microbiology; Mice; Microbial Sensitivity Tests; Spleen/microbiology; Tuberculosis/microbiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Isoniazid / Mycobacterium tuberculosis / Antitubercular Agents Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 1999 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google